Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
Active, not recruiting · NCT06192758 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device | cancer, chromosome 2q32-q33 deletion syndrome, neoplasm | Active, not recruiting | Not applicable | 2026-09-28 | NCT06192758 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Scientific Corporation | 148 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern Memorial Hospital | Chicago | United States | 129 |